Filing metadata

Accession number
0001567619-22-005190
Form type
Form 4
Filer
Cambrian BioPharma Inc
CIK
CIK 1797409
Filed
Feb 22, 2022
Reporting period
Feb 17, 2022
Description
Insider transaction

Explore SEC Filings Hub